Category : Orthopedic Oncology / Orthopaedics
Abemaciclib significantly prolonged PFS compared with placebo for patients with advanced dedifferentiated liposarcoma, according to findings presented during ASCO Annual Meeting’s plenary session.
Source : Healio
On : 19-Jun-2026